Search the Newsreel

Emyria (ASX:EMD) turns a psychedelic-therapy network into revenue as its national clinic rollout gathers pace

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Kirby McInerney LLP is investigating Myriad Genetics, Inc. (NASDAQ: MYGN) following a significant stock price decline after the company reported an 11% year-over-year revenue decrease in Q2 2026 and reduced its full-year guidance. The decline was attributed to issues with payer reimbursement and revenue-cycle …

Myriad Genetics Faces Multiple Investor Investigations

Myriad Genetics (NASDAQ: MYGN) is facing multiple investor investigations from several law firms after reporting weaker-than-expected second-quarter results and sharply reducing its 2026 revenue outlook. The company's stock lost nearly half its value following the announcement, prompting inquiries into whether Myriad Genetics or its …

Assenagon Asset Management S.A. Has $3.51 Million Stock Position in MYR Group, Inc. $MYRG

Assenagon Asset Management S.A. significantly reduced its stake in MYR Group, Inc. by 63% in the second quarter, now holding 7,022 shares valued at $3.51 million. Despite insider selling by two directors totaling $8.17 million, institutional investors still collectively own 88.9% of the company, …

Dimensional Fund Advisors LP Reduces Stake in Myriad Genetics, Inc. $MYGN

Dimensional Fund Advisors LP significantly reduced its stake in Myriad Genetics, Inc. by 42.6% in the first quarter, selling over half a million shares. This move comes as institutional investors hold a substantial portion of the company, and analysts have become more bearish, issuing …

Assenagon Asset Management S.A. Reduces Holdings in Myriad Genetics, Inc. $MYGN

Assenagon Asset Management S.A. significantly reduced its stake in Myriad Genetics, Inc. by 28.7% in the second quarter, selling over 415,000 shares. This divestment follows Myriad Genetics reporting disappointing quarterly results, missing analyst expectations for both earnings and revenue, and experiencing a year-over-year revenue …

Bull of the Day: MYR Group Inc. (MYRG)

MYR Group Inc. (MYRG) is highlighted as a strong buy-and-hold stock benefiting from megatrends like AI, energy, and electrification, with significant revenue and earnings growth projected. The specialty electrical contractor received a Zacks Rank #1 (Strong Buy) following strong quarterly results and upward earnings …

The Technical Signals Behind (MYRG) That Institutions Follow

Myr Group Inc. (NASDAQ: MYRG) is exhibiting weak near and mid-term sentiment which could challenge its positive long-term outlook, with no clear price positioning signal identified and elevated downside risk. Stock Traders Daily's AI models have generated three distinct trading strategies (Position, Momentum Breakout, …

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. (NASDAQ: MYGN) securities. This investigation follows Myriad's Q2 2026 revenue report, which showed an 11% year-over-year decrease and fell short of Wall Street estimates, leading the company …

Is MYR Group (MYRG) Undervalued Following Strong Q2 2026 Sales And Earnings?

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky is investigating Myriad Genetics (MYGN) for potential securities law violations after the company reported lower-than-expected Q2 2026 revenue, cut its full-year revenue guidance, and suspended adjusted EBITDA guidance. The investigation focuses on whether Myriad Genetics made materially false or misleading statements …

Myriad Genetics And 2 Other Promising Penny Stocks For Your Watchlist

This article identifies three promising penny stocks—Myriad Genetics (MYGN), Claros Mortgage Trust (CMTG), and Nextdoor Holdings (NXDR)—that exhibit strong financial health despite current challenges. Myriad Genetics is expanding its market reach through strategic partnerships, Claros Mortgage Trust has a solid cash runway despite unprofitability, …

MYR Group Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MYRG) 2026-08-08

This article announces the publication of MYR Group Inc.'s slide deck in conjunction with their 2026 Q2 earnings call. The content was provided by SA Transcripts, Seeking Alpha's team dedicated to publishing earnings call transcripts. The article highlights the availability of this presentation for …

MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS) has initiated an investigation into Myriad Genetics, Inc. (NASDAQ: MYGN) for potential securities law violations. This investigation follows Myriad's Q2 2026 financial results, which showed an 11% year-over-year revenue drop, reduced full-year guidance, and suspended EBITDA guidance, causing …

MYR Group, Inc. (MYRG) Stock Forecasts

Argus has lowered its target price for MYR Group Inc. (MYRG) to $357.00, citing the company's U.S.-based specialty electrical construction services. The stock is currently priced at $337.42. The article also lists related reports and market data.

Myriad Genetics (NASDAQ:MYGN) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen has downgraded Myriad Genetics (NASDAQ:MYGN) to a "Sell" rating from "Hold," citing the company's recent earnings miss and declining revenue. The stock opened significantly below its moving averages, and the analyst consensus for Myriad Genetics is now "Reduce" with an average …

MYR Group (NASDAQ:MYRG) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded MYR Group (NASDAQ:MYRG) from a "strong buy" to a "buy" rating, despite a broader analyst consensus of "Moderate Buy" and an average price target of $426. The company recently reported strong earnings, beating EPS estimates with $3.17 and achieving …

Form 8K MYR Group Inc For: 7 August By Investing.com

This article from Investing.com reports that MYR Group Inc. filed a Form 8K on August 7th. The brief news item includes the company's stock symbol MYRG and its current price performance, showing a 1.90% increase. The article itself is very concise, serving primarily as …

MYR Group (NASDAQ: MYRG) shows record revenue, earnings and backlog

MYR Group Inc. reported record financial performance for Q2 2026, with revenues reaching $1.08 billion, net income of $49 million, and diluted EPS of $3.17. The company's total backlog grew to $3.16 billion. For the trailing twelve months ended June 30, 2026, MYR Group …

MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. on Behalf of Myriad Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Myriad (MYGN) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Myriad and would like to discuss your legal rights, contact Bragar Eagel …

Myriad Genetics Inc (MYD.HA) stock price, news, quote and history

State Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics

State Street Corporation has disclosed a 5.3% beneficial ownership in Myriad Genetics, Inc. (MYGN), amounting to 4,985,060 shares. This ownership is managed through various asset management subsidiaries, with shared voting and dispositive power over the shares. The filing, a SCHEDULE 13G, indicates a passive …

Myriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating Myriad Genetics, Inc. (MYGN) after the company reported Q2 2026 revenues below Wall Street expectations and significantly cut its full-year 2026 revenue guidance. The firm encourages stockholders to contact them to learn more about the investigation into …

MYR Group, Inc. $MYRG Shares Acquired by California State Teachers Retirement System

California State Teachers Retirement System increased its stake in MYR Group, Inc. by 23.9% in the first quarter, now owning 18,260 shares valued at approximately $5.16 million. Institutional investors hold 88.9% of the company, which recently reported strong quarterly results with EPS of $3.17 …

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential securities claims against Myriad Genetics, Inc. (MYGN) after the company reported significantly lower-than-expected Q2 2026 revenue and drastically cut its full-year 2026 guidance. This announcement followed Myriad Genetics reiterating stronger guidance just three months prior, leading …

Sei Investments Co. Has $4.94 Million Stake in MYR Group, Inc. $MYRG

Sei Investments Co. increased its stake in MYR Group, Inc. (NASDAQ:MYRG) by 68.8% in the first quarter, now holding 17,498 shares valued at $4.94 million. Institutional investors own 88.9% of the company, while two directors recently sold shares totaling approximately $8.17 million. MYR Group …

MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP

Kirby McInerney LLP has announced an investigation into Myriad Genetics, Inc. (NASDAQ: MYGN) for potential securities fraud. This follows Myriad Genetics' report of an 11% year-over-year revenue decline in Q2 2026, reduced full-year guidance, and a significant stock price drop after the announcement. The …

Royal Bank of Canada Sells 11,461 Shares of MYR Group, Inc. $MYRG

Royal Bank of Canada reduced its holdings in MYR Group, Inc. by 11.4% in the first quarter, selling 11,461 shares and retaining 89,192 shares valued at approximately $25.2 million. Other institutional investors also adjusted their positions, and institutional investors collectively own 88.90% of MYR …

Myriad Genetics, Inc. (MYGN) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel

Johnson Fistel, PLLP is investigating Myriad Genetics, Inc. (MYGN) for potential federal securities law violations after the company reported an 11% year-over-year revenue decline and reduced its annual guidance. This decline was attributed to issues like lower reimbursement and unfavorable estimate changes, leading to …

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.34, Implies 87% Upside

Myriad Genetics, Inc.'s average 12-month price target has been lowered by analysts from $5.44 to $5.34, with forecasts ranging from $3 to $10. This updated target suggests an approximate 87% potential upside based on the July 31 closing price. Despite the target cut, the …

MYRG Q2 Deep Dive: Margin Expansion and Acquisition Bolster Growth Outlook

MYRG Q2 Deep Dive: Margin Expansion and Acquisition Bolster Growth Outlook Electrical construction and infrastructure services provider MYR Group (NASDAQ:MYRG) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 20.1% year on year to $1.08 billion. Its non-GAAP profit of …

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN)

Levi & Korsinsky, LLP has announced an investigation into Myriad Genetics (NASDAQ: MYGN) after the company significantly cut its full-year 2026 revenue guidance and suspended adjusted EBITDA guidance. This comes just three months after reaffirming higher revenue projections, leading to investor losses. The firm …

Why Myriad Genetics (MYGN) Is Down 49.0% After Cutting 2026 Revenue Outlook On Prenatal Weakness

Myriad Genetics (MYGN) shares dropped 49% after the company cut its 2026 revenue outlook to US$770-790 million, down from US$190.7 million, primarily due to weaker Prenatal Health test volumes. Despite a narrowed net loss, the reduced forecast highlights ongoing pressure on test volumes and …